Comparison of ziprasidone and olanzapine on cognitive function in patients with schizophrenia at different stages: a prospective study in Huai'an, China

齐拉西酮与奥氮平对不同阶段精神分裂症患者认知功能影响的比较:一项在中国淮安开展的前瞻性研究

阅读:3

Abstract

OBJECTIVE: To compare the effects of ziprasidone and olanzapine on cognitive function in patients with first-episode schizophrenia and chronic schizophrenia at different stages. METHODS: Cognitive function tests were performed on chronic schizophrenic patients who took olanzapine for a long time, first-episode drug-free schizophrenic patients, and healthy controls. RESULTS: There were significant differences in the digit span test, Stroop color and word test, auditory verbal learning test N2, N3, N4, trail-making test, verbal fluency test, and clock drawing test between first-episode drug-free schizophrenic patients and healthy controls (p < 0.05). Compared with patients with chronic schizophrenia, there were significant differences in the digit span test, Stroop color and word test B, auditory verbal learning test, trail making test B, and clock drawing test in patients with first-episode schizophrenia after 4 weeks of olanzapine treatment (p < 0.05). Compared with patients with chronic schizophrenia after 4 weeks of Ziprasidone treatment, patients with first-episode schizophrenia had significant differences in the digit span test, Stroop color, and word test, auditory verbal learning test N3, and clock drawing test after 4 weeks of olanzapine treatment (p < 0.05). Compared with patients with chronic schizophrenia who were treated with Ziprasidone for 12 weeks, there were significant differences in Stroop color and word test A, auditory verbal learning test N3, and clock drawing test in patients with first-episode schizophrenia after 4 weeks of olanzapine treatment (p < 0.05). CONCLUSION: Patients with schizophrenia have cognitive dysfunction in the early stage of onset. The combination of ziprasidone and olanzapine can effectively improve cognitive dysfunction and promote the recovery of social functions of patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。